SCHEMBL25565746

SCHEMBL25565746

CCN(CCCNC(C)C)CCCNC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAOX Q6QHF9 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
HRH3 Q9Y5N1 2/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
MITF O75030 1/20 0.33
NSD2 O96028 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25569452 0.96 PAOX (0.38) PAOXALDH1A1CHRM2HTR1AADRA2A
SCHEMBL19546118 0.96 PAOX (0.34) PAOXALDH1A1CHRM2HTR1AADRA2A
SCHEMBL152809 0.95 PAOX (0.40) PAOXALDH1A1HRH3APAF1NPC1
SCHEMBL25566310 0.93 PAOX (0.35) PAOXALDH1A1CHRM2HTR1AADRA2A
SCHEMBL25075491 0.92 EPHX1 (0.33) PAOXALDH1A1HRH3
SCHEMBL10617953 0.92 CYP1A2 (0.41) PAOXALDH1A1CHRM2ADRA2ACHRM1
SCHEMBL23384019 0.88 PAOX (0.39) PAOXALDH1A1CHRM2HRH3APAF1
SCHEMBL25075473 0.88 EPHX1 (0.35) PAOXALDH1A1SIGMAR1
SCHEMBL21954706 0.87 HRH4 (0.33) HRH3HRH4
SCHEMBL17766692 0.85 HRH4 (0.32) HRH3HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11859201-B2 Nanoparticle compositions containing sugar functionalized nucleic acid carriers TIBA BIOTECH LLC (US) 2024-01-02 US disclosed
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY POLN, TLR9, TSG101 PAOX 1186/4885ALDH1A1 3979/4885CHRM2 4667/4885
US-11859201-B2 Nanoparticle compositions containing sugar functionalized nucleic acid carriers TLR9, TLR3, TSG101 PAOX 3387/4885ALDH1A1 3422/4885CHRM2 4752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.